Dupilumab Demonstrates Histologic, Endoscopic Improvement in

Results showed higher-exposure dupilumab met the study’s primary endpoint for peak esophageal intraepithelial count ≤6 eos/high-power field.

Related Keywords

Vancouver , British Columbia , Canada , Mirna Chehade , American College Of Gastroenterology , Mount Sinai , American College , Scientific Meeting , E Histologic Scoring System , E Endoscopic Reference Score , Eosinophilic Esophagitis , Ceoe , Phase 3 , Trial , Study , Pediatric , Safety , Efficacy , Dupilumab ,